Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus
Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus
复制标题
DOI:
10.1002/art.22524
复制
发表时间:
2007-05-01
影响因子:
--
通讯作者:
Remuzzi, Giuseppe
中科院分区:
文献类型:
--
作者:
Benigni, Ariela;Caroli, Cristina;Remuzzi, Giuseppe
Objective. Toll-like receptor 9 (TLR-9), a receptor for CpG DNA, has been implicated in the activation of immune cells in lupus. We undertook this study to determine whether the expression of TLR-9 in resident renal cells in lupus nephritis is related to the development of tubulointerstitial injury.Methods. TLR-9 was analyzed in selectively retrieved renal tissue from (NZB X NZW)F-1 mice at different stages of disease by laser capture microdissection combined with real-time quantitative reverse transcriptase-polymerase chain reaction, and in renal biopsy specimens from lupus nephritis patients by immunohistochemistry. We investigated for the molecular component responsible for TLR-9 activation by cultured proximal tubular cells in serum from patients with lupus.Results. Renal tissue from NZB X NZW mice displayed robust TLR-9 expression localized to proximal tubular cells. TLR-9 levels correlated with proteinuria and tubulointerstitial injury to the extent that a cyclin-dependent kinase inhibitor, while reducing proteinuria and renal structural damage, prevented tubular TLR-9 generation in lupus mice. Consistently, exaggerated TLR-9 staining was found in proximal tubular cells of lupus patients, which correlated with tubulointerstitial damage. DNA-containing immune complexes purified from sera of patients with lupus induced TLR-9 in cultured proximal tubular cells. This was prevented by CCGG-rich short oligonucleotides, specific antagonists of CpG DNA, indicating that the DNA component of immune complexes was required for TLR-9 stimulation.Conclusion. These findings suggest that tubular TLR-9 activation has a pathogenetic role in tubulointerstitial inflammation and damage in experimental and human lupus nephritis, and they indicate a novel target for future therapies.